資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/32678
|
| 標題: | The burdens of tuberculosis on patients with malignancy: incidence, mortality and relapse |
| 作者: | Shu, Chin-Chung
Liao, Kuang-Ming
Chen, Yi-Chen
Wang, Jhi-Joung
Chung-Han Ho(何宗翰) |
| 貢獻者: | Natl Taiwan Univ Hosp, Dept Internal Med
Natl Taiwan Univ, Coll Med
Chi Mei Med Ctr, Dept Internal Med
Chi Mei Med Ctr, Dept Med Res
Southern Taiwan Univ Sci & Technol, Al Biomed Ctr
Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth CareAdm |
| 關鍵字: | LUNG-CANCER PATIENTS
ACTIVE TUBERCULOSIS
RISK
INFECTION
TB
MULTICENTER
SURVIVAL |
| 日期: | 2019-08 |
| 上傳時間: | 2020-07-29 13:54:56 (UTC+8) |
| 出版者: | NATURE PUBLISHING GROUP |
| 摘要: | Population with malignancy is growing worldwide; however, its tuberculosis (TB) burden including remains unclear regarding incidence, mortality, and relapse. We retrieved information and identified patients with malignancy and TB between 2000 and 2015 from the Taiwanese National Health Insurance reimbursement datasets, Taiwan cancer registry and death registration. We analyzed the incidence of new TB in patients with malignancy and their mortality as well as TB recurrence. During study period, we reviewed 1,105,009 patients after exclusion and among them, 19,906 had newly diagnosed TB. The TB incidence in cancer patients divided all TB events increased annually, from 3% in 2000 to 13% in 2015. The standard incidence rates (SIR) were highest in cancer of respiratory tract (5.45), hematology (3.70) and then head and neck area (2.58). The mortality directly due to TB was defined as 0.83% and all-cause mortality were approximately 10.5% at 3 months and 20.56% at 12 months. After completing TB treatment, recurrence was diagnosed in 626 (3.14%), and 1001 (5.03%) patients within the first and the first two years, respectively. In conclusion, the incidence of TB in patients with malignancy increase yearly as well as its proportion within overall cases. The twelve-month all-cause mortality during TB and the two-year recurrence are as high as 20.56% and 5.03%, respectively. It indicates the importance of this population in future TB control, especially for those with malignancy of respiratory tract, and hematology as well as head and neck area. |
| 關聯: | Scientific Reports, v.9, n11901 |
| 顯示於類別: | [醫務管理系(所)] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| 10.1038-s41598-019-48395-8.pdf | | 1093Kb | Adobe PDF | 445 | 檢視/開啟 | | index.html | | 0Kb | HTML | 994 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
